Desjardins initiated coverage of High Tide with a rating of Buy
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/22/2022 | $7.75 → $7.25 | Neutral | Cantor Fitzgerald |
| 12/10/2021 | $8.75 → $7.75 | Neutral | Cantor Fitzgerald |
| 11/23/2021 | Neutral | Cantor Fitzgerald | |
| 11/23/2021 | $8.75 | Neutral | Cantor Fitzgerald |
| 9/13/2021 | $12.00 | Buy | ROTH Capital |
| 9/3/2021 | Buy | Desjardins | |
| 9/3/2021 | $15.00 | Buy | Desjardins |
CALGARY, AB, Dec. 23, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to reflect on its key milestones achieved in 2025, a year in which the Company continued to deliver strong results while executing against its publicly stated strategic and operational objectives. From surpassing 200 stores and more than 2 million Canadian Cabana Club members, to officially entering the German medical cannabis market, the Company consistently executed against its strategic priorities while strengthening its operations and financ
CALGARY, AB, Dec. 22, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that the Company will be participating in the ICR Conference in Orlando, Florida, hosting two days of meetings with institutional investors. Raj Grover, Founder and Chief Executive Officer of High Tide, will participate in a fireside chat moderated by Bill Kirk, Managing Director, Senior Research Analyst at ROTH Capital Partners, that is scheduled to begin at 8:00 a.m. EST on Tuesday, January 13, 2026.
The Company confirms it is assessing U.S. licensing pathways for its Canna Cabana retail brand NuLeaf Naturals and FAB CBD evaluating Medicare-aligned product categories CALGARY, AB, Dec. 18, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, today welcomed the Executive Order issued by the White House advancing the rescheduling of cannabis as well as an announcement that the Centers for Medicare & Medicaid Services is expected to launch a pilot program allowing certain Medicare beneficiaries to receive CBD treatments at no cos
6-K - High Tide Inc. (0001847409) (Filer)
6-K - High Tide Inc. (0001847409) (Filer)
6-K - High Tide Inc. (0001847409) (Filer)
Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.25 from $7.75 previously
Cantor Fitzgerald reiterated coverage of High Tide with a rating of Neutral and set a new price target of $7.75 from $8.75 previously
Cantor Fitzgerald initiated coverage of High Tide with a rating of Neutral
Same-Store Sales Were Up 7.4% Year Over Year, the Fastest Growth Rate in Two YearsThe Company Reports $7.7 Million in Free Cash Flow in Q3 2025, Up 148% Year Over Year, and 57% SequentiallyThe Company Reports Positive Net Income of $832 Thousand, Up 1% Year Over Year and Marked a Meaningful Reversal Versus a Net Loss of $2.8 Million SequentiallyDuring May 2025 and June 2025, Canna Cabana Held a 12% Share of the Cannabis Retail Market Across the Five Provinces in Which the Company Has a Presence, Up From 11% in the Previous Year1 High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars.2 Q3 Annualized Revenue Run Rate Was Approximately $600 MillionCALGAR
CALGARY, AB, Sept. 2, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to announce, that further to its press release dated August 14, 2025 (the "August 14 Release"), the Company has completed the acquisition of a 51% interest in Remexian for an estimated purchase price of €26.4 million, such amount to be finalized in 30 days, once the final closing balance sheet is available, and will have a five-year option to acquire the remaining 49% of Remexian at any time after 24 months. Capitalized terms not otherwise defin
The Company Expects Record Revenue, Adjusted EBITDA Ahead of Analyst Forecasts and a Two-Year High in Same-Store Sales Growth The Company Also Shares Details of Its Q3 2025 Earnings Event CALGARY, AB, Aug. 18, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to release guidance estimates regarding anticipated results for its third fiscal quarter ended July 31, 2025. Management Guidance Range (Expres
Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase
CALGARY, AB, Aug. 12, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to provide several corporate updates. Germany Update High Tide is pleased to share that it continues to make solid progress on the previously disclosed proposed transaction with a leading German medical cannabis importer and wholesaler. This contemplated transaction is already fully funded following the junior secured loan the Com
CALGARY, AB, May 30, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today the voting results from its annual general and special meeting of shareholders of the Company held on May 29, 2025 (the "Meeting"). Each nominee listed in the Company's management information circular dated April 17, 2025, was elected as a director of the Company. Each of the following five nominees proposed by management was